Contact lenses, which we often see in games and science fiction movies, and which add real-time information to our vision, are getting closer to being real as technology improves. In these days when we talked about Metaverse and expressed that we would virtualize our world with glasses, some important developments were also shared about lenses.
For example, at the CES 2022 event recently, a company called Mojo Vision introduced its sports-focused lens, which it developed in partnership with Adidas. The wearer of this lens was transporting digital displays to the real world and seeing them. While Mojo Vision managed to attract attention with this lens, another company showed up at CES 2022 with the same vision, but with a completely different technology.
Soft contact lenses can be switched:
Flexable circuit representation in soft lens
A company called InWith, which focuses on smart technologies, introduced the “soft contact lens platform” called “XR Platform”, which it developed with a focus on metaverse. The company paved the way for soft contact lenses to be circuited. The first applications of the technology will offer ‘adjustable vision’ on a mobile device and ‘augmented vision’ that can be controlled with a mobile device. The most basic feature that the lenses will offer will be to provide an easy transition between real life and Metaverse.
InWith originally started to announce its work on this technology in 2020. The company demonstrated its ‘flexible electronic circuit’ technology in 2020 and managed to attract attention. Thanks to the technology demonstrated at CES 2022, developers will be able to embed an augmented image imaging chip in any soft hydrogel contact lens.
The company announced that it is currently working with Fortune 50 companies to bring to market the first usable examples of this technology with several hundred patents. The company is the only company that has succeeded in integrating component circuits into modern soft contact lens materials and publicly displaying it. The technology will enable contact lenses to display metaverse and augmented reality, as well as a cure for people suffering from myopia and presbyopia. The company plans to seek clearance from the U.S. Food and Drug Administration this year.
37441
